Research & Clinical Trials
Concerning COVID-19 Only
All the advancements in preventing and treating COVID-19 are due to the brave volunteers who entered clinical trials for vaccines, monoclonal antibodies for both treatment and prevention, and antivirals. Here you will find both the results of important trials giving us the information needed to best navigate the pandemic and information about appropriate open trials that offer access to new cutting-edge therapies.
ADDITIONAL READING
On October 11, 2021, AstraZeneca announced the topline results from their Phase III TACKLE trial in outpatient treatment with AZD7442 for patients with early, mild to moderate COVID-19.
We still have work to do, but for right now, let’s celebrate this major win for CLL and other immunocompromised patients.
We still have work to do, but for right now, let’s celebrate this major win for CLL and other immunocompromised patients.
At the annual meeting of the American Society of Hematology (ASH) 2020, our own Dr. Brian Koffman interviewed Dr. Lindsey Roeker, a hematologic oncologist at Memorial Sloan Kettering Cancer Center. They discussed new data looking at COVID-19 vaccine response in patients with CLL.
Research pertaining to when CLL meets COVID-19 is only just beginning. There is no doubt that studies will rapidly accelerate over the next year and are sure to include the CLL patient’s response to vaccines. Dr. Lindsey Roeker of Memorial Sloan Kettering (MSK) in NYC moves the field forward
There has been much excitement about the possibility that BTK inhibitors such as ibrutinib or acalabrutinib might improve outcomes in COVID-19 for all patients ever since Dr. Treon published a retrospective study on his patients with Waldenstrom macroglobulinemia, a B-cell cancer similar to CLL, who did well while on
RECENT NEWS
When appropriate, the CLL Society will be posting updates and background information on the present Coronavirus pandemic focusing on reliable primary sources of information and avoiding most of the news that is not directly from reliable medical experts or government and world health agencies.
